Bausch + Lomb (BLCO) stock has seen an increase due to rumors of a potential buyout and FDA approval.
Related stocks include BLCO…
Bausch + Lomb saw its target price increased by Deutsche Bank Aktiengesellschaft from $14.00 to $18.00 in a report released on Thursday, according to Benzinga.
Deutsche Bank Aktiengesellschaft raises Bausch + Lomb’s price target to $18.00. Read More »